Weil Steers Bard In $262M Rochester Medical Buy
Bard will pay $20 per Rochester share, a nearly 45 percent premium on Tuesday's closing price. The all-cash deal has the blessing of both companies' board of directors and would make Rochester a wholly owned subsidiary of Bard, according to the companies.
The deal is expected to give...
Already a subscriber? Click here to login